热门资讯> 正文
Fulgent Genetics获得欧盟批准种系测序系统
2025-07-17 22:16
- Fulgent Genetics (NASDAQ:FLGT) has received European Union’s CE certification for its germline next-generation sequencing system.
- This system includes FulgentExome and Fulgent Pipeline Manager, complying with the European Union’s in vitro diagnostic regulation.
More on Fulgent Genetics
- Fulgent Genetics: A 'Sum Of The Parts' Story
- Fulgent Genetics, Inc. (FLGT) Q1 2025 Earnings Call Transcript
- Fulgent genetics targets $310M core revenue in 2025 with strong growth in diagnostics and pathology
- Fulgent Genetics rises on earnings, revenue beat
- Seeking Alpha’s Quant Rating on Fulgent Genetics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
